Sysmex Inostics is a leader in blood-based cell-free tumor DNA oncology testing services. The company’s OncoBEAM™ assays detect clinically actionable gene mutations in cancer allowing for more targeted therapies and monitoring of disease response and recurrence. Sysmex Inostics has a CLIA-certified laboratory in Baltimore, Maryland and a GCP laboratory in Hamburg, Germany. The company also offers global comprehensive services for Pharmaceutical and CRO companies— from discovery to companion diagnostics.
